MedTrace Logo

COVID-19 Advanced Respiratory Physiology (CARP) Study

NCT04668313 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-12-16

No results posted yet for this study

Summary

The anticipated second wave of COVID-19 cases will present healthcare system challenges, including requirement to monitor large numbers of patients for deteriorating respiratory failure. Rising respiratory rate can identify deterioration requiring escalation of care. However constant monitoring of respiratory rate can be challenging outwith critical care units due to feasibility and inaccuracy of intermittent measurements.

Wearable biosensors which allows for remote patient monitoring of RR is therefore attractive, particularly when combined in a dashboard with clinical summary data. This would establish source data and infrastructure for the training and validation of machine-learning models, with decision support risk-predictions prioritising alerts and clinician reviews.

Conditions

Sponsors & Collaborators

  • Altair Medical

    collaborator UNKNOWN

  • Storm ID

    collaborator UNKNOWN

  • NHS Greater Glasgow and Clyde

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2020-12-30
Completion
2021-09-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668313 on ClinicalTrials.gov